Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FAMILIELÆGEN LÆGEHUSET NYENSTAD ALMENT PRAKTISERENDE LÆGER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.4% 1.3% 1.3% 1.4% 1.5% 1.0% 18.5% 18.2%   Credit score (0-100)   80 82 81 77 76 84 8 8   Credit rating   A A A A A A B B   Credit limit (kDKK)   35.5 68.8 88.9 35.2 20.7 168.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,397 6,336 7,216 6,850 7,313 6,260 0.0 0.0   EBITDA   1,592 1,567 2,261 2,015 2,044 1,182 0.0 0.0   EBIT   1,560 1,513 2,207 1,968 1,997 1,003 0.0 0.0   Pre-tax profit (PTP)   1,560.0 1,513.0 2,194.3 1,950.5 1,994.1 1,007.6 0.0 0.0   Net earnings   1,217.0 1,180.0 1,701.9 1,521.0 1,555.3 785.5 0.0 0.0   Pre-tax profit without non-rec. items   1,560 1,513 2,194 1,950 1,994 1,008 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   366 427 374 326 279 232 0.0 0.0   Shareholders equity total   1,377 1,357 1,889 1,710 1,745 991 84.5 84.5   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0   Balance sheet total (assets)   2,000 2,442 3,247 2,634 2,715 1,856 84.5 84.5   Net Debt   -1,044 -1,472 -2,069 -1,557 -1,911 -1,041 -84.5 -84.5     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,397 6,336 7,216 6,850 7,313 6,260 0.0 0.0   Gross profit growth   5.6% -1.0% 13.9% -5.1% 6.8% -14.4% -100.0% 0.0%   Employees   6 5 6 6 6 6 0 0   Employee growth %   0.0% -16.7% 20.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,000 2,442 3,247 2,634 2,715 1,856 85 85   Balance sheet change%   11.0% 22.1% 33.0% -18.9% 3.1% -31.6% -95.4% 0.0%   Added value   1,592.0 1,567.0 2,261.1 2,015.3 2,044.1 1,182.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   100 7 -107 -95 -95 -226 -232 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.4% 23.9% 30.6% 28.7% 27.3% 16.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   82.1% 68.1% 77.6% 66.9% 74.7% 44.3% 0.0% 0.0%   ROI %   120.5% 104.9% 124.9% 100.8% 110.3% 72.0% 0.0% 0.0%   ROE %   95.2% 86.3% 104.9% 84.5% 90.0% 57.4% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   68.9% 55.6% 58.2% 64.9% 64.3% 53.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -65.6% -93.9% -91.5% -77.3% -93.5% -88.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 3.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 26.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   4.9 2.9 3.7 5.5 4.8 2.2 0.0 0.0   Current Ratio   4.9 2.9 3.7 5.5 4.8 2.2 0.0 0.0   Cash and cash equivalent   1,044.0 1,472.0 2,069.4 1,557.4 1,910.7 1,077.4 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,300.0 1,323.0 2,088.4 1,889.7 1,928.2 895.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   265 313 377 336 341 197 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   265 313 377 336 341 197 0 0   EBIT / employee   260 303 368 328 333 167 0 0   Net earnings / employee   203 236 284 254 259 131 0 0